Guides And Explainers

Unveiling the CNBC Dirty Dozen 2017: A Deep Dive into the

Hey there, investors! Ever found yourself entangled in the hype surrounding certain stocks, only to realize you've been lured into a CNBC Dirty Dozen trap? Well, you're not alon...

Mara Ellison
Unveiling the CNBC Dirty Dozen 2017: A Deep Dive into the

Unveiling the CNBC Dirty Dozen 2017: A Deep Dive into the World's Most Overhyped Stocks

Hey there, investors! Ever found yourself entangled in the hype surrounding certain stocks, only to realize you've been lured into a CNBC Dirty Dozen trap? Well, you're not alone. CNBC's annual list of the most overhyped stocks is back, and we're diving in to explore the CNBC Dirty Dozen 2017 – the companies that captured Wall Street's imagination a little too well. Guys, explore more in Guides And Explainers and cnbc dirty dozen 2017.

What's the Big Deal with the CNBC Dirty Dozen?

Before we get started, let's clear the air: being named in the CNBC Dirty Dozen isn't an official indictment of a company's prospects. It's more of a public service announcement, warning investors about stocks that have been getting an unhealthy amount of attention. After all, fame is fleeting, and so is the hype surrounding these companies.

The CNBC Dirty Dozen 2017: A Roll Call

Alright, let's meet the CNBC Dirty Dozen 2017. Remember, we're not here to bash these companies; we're just shining a light on the hype surrounding them.

1. Snap (SNAP)

Snapchat's parent company, Snap, took the tech world by storm with its IPO in 2017. But with a market cap that's skyrocketed and a product that's facing stiff competition, is the hype justified?

2. Tesla (TSLA)

Elon Musk's electric vehicle (EV) and clean energy company has been a darling of the market for years. But with production issues and a high stock price, is Tesla living up to the hype?

3. Blue Apron (APRN)

This meal kit delivery service was once the darling of the food tech industry. But after a rocky IPO and increased competition, is Blue Apron still a hot stock?

4. Mylan (MYL)

The pharma company faced a backlash in 2016 for hiking the price of its EpiPen. But with a new CEO and a focus on generics, is Mylan's hype warranted?

5. Amazon (AMZN)

Need we say more? The everything store has been on a tear, expanding into cloud computing, streaming services, and even physical stores. But can it keep up the pace?

6. Netflix (NFLX)

Netflix's subscriber growth and original content have been the talk of the town. But with increased competition and a mountain of debt, is the streaming giant living up to the hype?

7. Chipotle (CMG)

After a food safety crisis, Chipotle's stock took a hit. But with a new CEO and a focus on digital ordering, is the burrito chain back in the good graces of investors?

8. Valeant Pharmaceuticals (VRX)

Once a high-flying pharma company, Valeant's reputation was tarnished by accounting issues and price-gouging. But with a new management team, is Valeant back on track?

9. Under Armour (UAA)

This athletic apparel company was once a Wall Street darling. But with slowing sales and increased competition, is Under Armour still a hot stock?

10. Twitter (TWTR)

After a rocky start, Twitter has been trying to turn its fortunes around. But with a stagnant user base and a controversial CEO, is Twitter living up to the hype?

11. GoPro (GPRO)

This action camera company was once a hot stock. But with slowing sales and increased competition, is GoPro still a must-own stock?

12. Yelp (YELP)

This review site has been facing increased competition and slowing growth. But with a new CEO and a focus on local advertising, is Yelp still a relevant stock?

Lessons from the CNBC Dirty Dozen 2017

So, what can we learn from the CNBC Dirty Dozen 2017? Here are a few key takeaways:

- Hype fades: Stocks that get too much attention can quickly fall out of favor. It's important to do your own research and not get swept up in the hype. - Fundamentals matter: A company's financial health and business prospects are more important than its stock price or media buzz. - Diversification is key: Don't put all your eggs in one basket. Spread your investments across multiple sectors and companies to minimize risk. - Patience is a virtue: Great companies take time to build. Don't be swayed by short-term noise or hype.

The Bottom Line

The CNBC Dirty Dozen 2017 is a useful reminder that not all hype is created equal. While these companies may be capturing Wall Street's attention, it's up to us to separate the signal from the noise. So, the next time you hear about a stock that's "crushing it" or "revolutionizing an industry," take a step back and do your own research. After all, the market rewards patience and diligence, not hype.

Stay smart, stay informed, and happy investing!

(Word count: 1500)

Related Reading

More pages in this topic cluster.

Embarking on the Ultimate Medical Adventure: Your Doctor

Hey there, explorers of the medical world! Are you ready to dive into an epic journey through the alphabet, where each letter unveils a fascinating aspect of healthcare? Welcome...

Read next
Unveiling the Best Handheld Red Light Therapy Devices

Hey there, health enthusiasts! Today, we're diving into the world of red light therapy and exploring some of the best handheld red light therapy devices that can help you boost...

Read next
Eva Longoria's Sisterly Bond: A Deep Dive into Eva

Hello there, Eva Longoria fans! Today, we're diving deep into the wonderful world of Eva Longoria Hermanas , exploring the tight-knit bond between Eva and her sisters. So, grab...

Read next